Instead of using the controversial body mass index, or BMI, to assess weight, an international group of scientists proposes ...

Novo Nordisk said on Friday a late-stage trial with a high-dose version of its weight loss drug semaglutide helped overweight ...

India has experienced a doubling of obesity prevalence over the past two decades, with abdominal obesity becoming ...

A panel of health experts looking at obesity announced that the definition of the condition should be split into two ...

Despite the staggering impact of obesity on the Black community, columnist Justice B. Hill argues that the issue has been ...

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide ...

A global group of experts has suggested a new approach to diagnosing and treating obesity that does not rely solely on the much-contested body mass index (BMI).

The way clinicians diagnose obesity is set to change with new guidelines acknowledging that not all obese have the same ...

Former Trump administration health official Joe Grogan applauds Biden proposal that Medicare and Medicaid cover GLP-1 ...

Diabetes and weight loss drugs Ozempic and Wegovy have been added to the list of medications selected for Medicare price ...

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...

Novo Nordisk said patients taking a bigger dose of its blockbuster obesity drug lost more weight than those on a lower dose, ...